Table 1.
Donor and recipient characteristics in different grades of steatotic groups.
| Variables | Mild steatosis (N = 111) | Moderate steatosis (N = 16) | Severe steatosis (N = 10) | Nonsteatosis (N = 223) | P |
|---|---|---|---|---|---|
| Preoperative donor parameters | |||||
| Donor age, years | 40.03 ± 1.03 | 38.38 ± 3.28 | 41.30 ± 5.06 | 37.29 ± 0.88 | 0.254 |
| Donor sex male n (%) | 89 | 15 | 10 | 173 | 0.162 |
| Donor type | |||||
| DBD | 102 | 15 | 10 | 205 | 0.972 |
| DCD | 8 | 1 | 0 | 17 | |
| DBCD | 1 | 0 | 0 | 1 | |
| BMI (kg/m2) | 22.17 ± 0.30 | 21.03 ± 0.95 | 20.95 ± 0.76 | 22.37 ± 0.22 | 0.250 |
| Cause of death | |||||
| Anoxia | 7 | 0 | 1 | 13 | 0.534 |
| Trauma | 53 | 11 | 7 | 126 | |
| Vascular | 49 | 5 | 2 | 76 | |
| Other | 2 | 0 | 0 | 8 | |
| AST (U/l) | 150.76 ± 24.50 | 84.56 ± 27.27 | 142.00 ± 21.29 | 107.30 ± 10.65 | 0.215 |
| ALT (U/l) | 77.88 ± 8.36 | 47.50 ± 9.22 | 90.50 ± 21.18 | 79.12 ± 6.68 | 0.589 |
| GGT (U/l) | 85.76 ± 10.02 | 74.25 ± 20.14 | 76.60 ± 29.26 | 86.88 ± 7.48 | 0.963 |
| Bilirubin (mmol/l) | 24.41 ± 1.63 | 22.08 ± 3.03 | 31.28 ± 7.79 | 27.27 ± 1.74 | 0.544 |
| CIT, h | 5.79 ± 0.3 | 5.50 ± 0.96 | 5.10 ± 1.22 | 5.99 ± 0.31 | 0.877 |
| Donor WIT, min | 1.17 ± 0.49 | 1.25 ± 0.69 | 0 | 0.62 ± 0.12 | 0.387 |
| ICG test result % | 4.77% ± 0.64% | 4.20% ± 2.0% | 3.52% ± 0.97% | 4.21% ± 0.41% | 0.882 |
| Preoperative recipient parameters | |||||
| Recipient age, years | 49.22 ± 1.12 | 53.56 ± 2.70 | 51.00 ± 2.50 | 60.67 ± 0.75 | 0.450 |
| Recipient sex male n (%) | 103 | 15 | 10 | 200 | 0.560 |
| BMI (kg/m2) | 23.37 ± 0.34 | 21.18 ± 0.90 | 21.73 ± 1.14 | 22.94 ± 0.25 | 0.101 |
| MELD | 18.58 ± 0.87 | 16.56 ± 2.33 | 19.30 ± 3.06 | 19.34 ± 0.71 | 0.708 |
| Diagnosis | |||||
| HCC | 64 | 9 | 3 | 121 | 0.330 |
| Cirrhotic | 31 | 6 | 7 | 68 | |
| Acute liver failure | 5 | 1 | 0 | 14 | |
| Others | 11 | 0 | 0 | 20 | |
| Transplantation parameters | |||||
| Anhepatic time, min | 55.06 ± 1.98 | 56.25 ± 5.58 | 60.50 ± 6.75 | 53.56 ± 1.29 | 0.661 |
| Intraoperative transfusions (U) | 6.31 ± 0.53 | 7.40 ± 1.84 | 8.23 ± 2.56 | 7.31 ± 0.53 | 0.637 |
| Blood loss (ml) | 2030.54 ± 165.96 | 3150.00 ± 842.12 | 2280.00 ± 254.65 | 2346.32 ± 184.23 | 0.351 |
| Type of vena cava anastomosis | |||||
| Classic | 52 | 5 | 3 | 90 | 0.821 |
| Classic piggyback | 8 | 2 | 1 | 21 | |
| Modified piggyback | 51 | 9 | 6 | 112 | |
| ICU length‐of‐stay (h) | 83.44 ± 12.66 | 43.28 ± 8.70 | 111.90 ± 73.70 | 73.31 ± 7.74 | 0.477 |
| Postoperative outcome parameters | |||||
| EAD | 33 | 7 | 5 | 22 | <0.001 |
| PNF | 1 | 0 | 2 | 1 | <0.001 |
| Biliary anastomotic strictures | 2 | 0 | 0 | 2 | 0.833 |
| Biliary leakage | 1 | 0 | 0 | 2 | 0.972 |
| Hepatic artery complications | 2 | 0 | 0 | 5 | 0.889 |
| Retransplantation | 1 | 0 | 0 | 2 | 0.972 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CIT, cold ischaemia time; DBCD, Donor after brain and cardiac death; DBD, donor after brain death; DCD, donor after cardiac death; EAD, early allograft dysfunction; GGT, γ‐glutamyl transpeptidase; HCC, hepatocellular carcinoma; ICG, indocyanine green; ICU, intensive care unit; IFLT, ischaemia‐free liver transplantation; MELD, model for end‐stage liver diseases; PNF, Primary nonfunction; WIT, warm ischaemia time.